My Authors
Read all threads
1/ Here is my summary of the relevant points from the breaking open-label clinical trial on the use of hydroxychloroquine (HCQ) and azithromycin in the treatment of COVID-19 by Didier Raoult, MD/PhD. @DiderRaoult
2/ Trial included 36 adult patients, 26 received HCQ & 16 controls. Six out of 42 patients meeting inclusion criteria lost to follow up. (All from treatment group: 3 transferred to ICU, 1 death, 1 left hospital, 1 stopped HCQ bc nausea. No control patients lost to follow-up.)
3/ HCQ-treated patients average age 51.2 yrs vs control patients average age of 37.3 yrs. Six patients receiving HCQ received azithromycin on day 1 (unclear how certain patients were selected to receive azithromycin).
4/ Control group:

HCQ treatment group:
-Oral HCQ sulfate, 200mg three times a day for 10 days

HCQ + Azithromycin treatment group:
-Oral HCQ sulfate, 200mg three times a day for 10 days
-Oral azithromycin, 500mg on day 1, followed by 250mg daily for 4 days
5/ Results on Day 6:
-12.5% of control patients virologically cured
-57.1% of HCQ treated patients virologically cured
-100% of HCQ + Azithromycin patients virologically cured
6/ Of note:
a) This is not my research.
b) This a small non-randomized clinical trial which had patient dropout in the treatment group.
c) I look forward to more clinical data on this treatment.
d) Please follow the recommendations of your doctor. This is not medical advice.
Missing some Tweet in this thread? You can try to force a refresh.

Enjoying this thread?

Keep Current with James Todaro, MD

Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

Twitter may remove this content at anytime, convert it as a PDF, save and print for later use!

Try unrolling a thread yourself!

how to unroll video

1) Follow Thread Reader App on Twitter so you can easily mention us!

2) Go to a Twitter thread (series of Tweets by the same owner) and mention us with a keyword "unroll" @threadreaderapp unroll

You can practice here first or read more on our help page!

Follow Us on Twitter!

Did Thread Reader help you today?

Support us! We are indie developers!

This site is made by just three indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3.00/month or $30.00/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!